rs150146721
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PP3_StrongPP5_Very_Strong
The NM_000140.5(FECH):c.1001C>T(p.Pro334Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000124 in 1,614,156 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/20 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000140.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FECH | NM_000140.5 | c.1001C>T | p.Pro334Leu | missense_variant | 9/11 | ENST00000262093.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FECH | ENST00000262093.11 | c.1001C>T | p.Pro334Leu | missense_variant | 9/11 | 1 | NM_000140.5 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152162Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251448Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135894
GnomAD4 exome AF: 0.000130 AC: 190AN: 1461876Hom.: 0 Cov.: 31 AF XY: 0.000127 AC XY: 92AN XY: 727240
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152280Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74450
ClinVar
Submissions by phenotype
Protoporphyria, erythropoietic, 1 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Jul 17, 2023 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with erythropoietic protoporphyria 1 (MIM#177000). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from proline to leucine. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v2) <0.01 for a recessive condition (14 heterozygotes, 0 homozygotes). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated ferrochelatase domain (DECIPHER). (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been classified as pathogenic or likely pathogenic by clinical laboratories in ClinVar, and had been observed in mulitple individuals with EPP (PMIDs: 20412370, 20105171, 30454868, 12601550, 17711525, 23364466). A second variant, commonly the known hypomorphic allele c.315-48T>C, was seen in many of these individuals but data was not always available to prove the variants were in trans. (SP) 1005 - Clinically accredited laboratory assay specific to gene product shows abnormal protein function. Analysis of this individual's red cell porphyrin has demonstrated abnormally high results consistent with erythropoietic protoporphyria (Prince of Wales Hospital, SEALS). (SP) 1206 - This variant has been shown to be paternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Knight Diagnostic Laboratories, Oregon Health and Sciences University | Jun 28, 2016 | The c.1001C>T (p.Pro334Leu) missense variant in the FECH gene has been previously reported in multiple families affected with Erythropoietic protoporphyria (Rüfenacht et al., 1998; Wiman et al., 2003). This variant been shown to segregate with disease in 3 unrelated families, and has been observed in trans with a known pathogenic variant, IVS3-48T>C (Wiman et al., 2003). Furthermore, an in vitro functional assay demonstrated that this variant resulted in reduced FECH activity (Rüfenacht et al., 1998). This variant is reported at low frequency in the population databases (Exome Sequencing Project = 0.047%; 1000 Genomes = 0.1%; and ExAC = 0.013%). Multiple in silico algorithms predict this variant to have a deleterious effect (GERP = 6.17; CADD = 27.1; PolyPhen = 1.0; SIFT = 0.0). Therefore, this collective evidence supports the classification of the c.1001C>T (p.Pro334Leu) as a Likely pathogenic variant for Erythropoietic protoporphyria. We have confirmed this finding in our laboratory using Sanger sequencing. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 27, 2023 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects FECH function (PMID: 9585598). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FECH protein function. ClinVar contains an entry for this variant (Variation ID: 375409). This missense change has been observed in individual(s) with erythropoietic protoporphyria (PMID: 9585598, 12601550, 15286165, 17711525, 23364466). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs150146721, gnomAD 0.01%). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 334 of the FECH protein (p.Pro334Leu). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at